237 related articles for article (PubMed ID: 6395814)
1. The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1984 Oct; 78(5):459-66. PubMed ID: 6395814
[TBL] [Abstract][Full Text] [Related]
2. Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis.
Win K; Thwe Y; Lwin TT; Win K
Lancet; 1985 Sep; 2(8457):694-5. PubMed ID: 2863679
[No Abstract] [Full Text] [Related]
3. Prevention of drug resistance in rodent malaria by the use of drug mixtures.
Peters W
Bull World Health Organ; 1974; 51(4):379-83. PubMed ID: 4619060
[TBL] [Abstract][Full Text] [Related]
4. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ
Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709
[TBL] [Abstract][Full Text] [Related]
5. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
Botero D; Restrepo M; Montoya A
Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium falciparum resistant to mefloquine plus sulfadoxine/pyrimethamine.
Heizmann P; Fernex M; Leimer R; Reber-Liske R; Stohler H
Lancet; 1986 Feb; 1(8477):377. PubMed ID: 2868309
[No Abstract] [Full Text] [Related]
7. RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
Hoffman SL; Rustama D; Dimpudus AJ; Punjabi NH; Campbell JR; Oetomo HS; Marwoto HA; Harun S; Sukri N; Heizmann P
Lancet; 1985 Nov; 2(8463):1039-40. PubMed ID: 2865518
[TBL] [Abstract][Full Text] [Related]
8. Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria.
Hall AP; Doberstyn EB; Karnchanachetanee C; Samransamruajkit S; Laixuthai B; Pearlman EJ; Lampe RM; Miller CF; Phintuyothin P
Br Med J; 1977 Jun; 1(6077):1626-8. PubMed ID: 326337
[TBL] [Abstract][Full Text] [Related]
9. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
[TBL] [Abstract][Full Text] [Related]
10. [Plasmodium falciparum drug resistance and sulfadoxine-pyrimethamine in Africa].
Randriamanjaka JR; Le Bras J; Charmot G; Coulaud JP
Bull Soc Pathol Exot Filiales; 1989; 82(3):381-4. PubMed ID: 2670291
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
Salako LA; Aderounmu AF; Laoye JO; Makinde JM; Adio RA
Ann Trop Med Parasitol; 1988 Aug; 82(4):325-30. PubMed ID: 3075441
[TBL] [Abstract][Full Text] [Related]
12. The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
Myint PT; Shwe T
Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):223-5. PubMed ID: 3313739
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial and toxic effect of triple combination of pyronaridine, sulfadoxine and pyrimethamine.
Shao BR; Huang ZS; Shi XH; Zhan CQ; Meng F; Ye XY; Huang J; Ha SH
Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):257-63. PubMed ID: 2692191
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
[TBL] [Abstract][Full Text] [Related]
15. Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria.
Li GQ; Arnold K; Guo XB; Jian HX; Fu LC
Lancet; 1984 Dec; 2(8416):1360-1. PubMed ID: 6150365
[TBL] [Abstract][Full Text] [Related]
16. Double-blind studies with mefloquine alone and in combination with sulfadoxine-pyrimethamine in 120 adults and 120 children with falciparum malaria in Vietnam.
Trinh KA; Nguyen VK; Arnold K; Vo VC; Nguyen NB; Kim T; Ladinsky J
Trans R Soc Trop Med Hyg; 1990; 84(1):50-3. PubMed ID: 2189246
[TBL] [Abstract][Full Text] [Related]
17. Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.
Karbwang J; Looareesuwan S; Phillips RE; Wattanagoon Y; Molyneux ME; Nagachinta B; Back DJ; Warrell DA
Br J Clin Pharmacol; 1987 Apr; 23(4):477-81. PubMed ID: 3555581
[TBL] [Abstract][Full Text] [Related]
18. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
Niklewski G; Landscheidt H; Glasner H
Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058
[No Abstract] [Full Text] [Related]
19. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
Ellis-Pegler RB; Beeching NJ; Eales M; Fraser AG; Wells AU
Aust N Z J Med; 1988 Aug; 18(5):733-4. PubMed ID: 3072955
[No Abstract] [Full Text] [Related]
20. New drugs and their potential use against drug-resistant malaria.
Warhurst DC
Ann Ist Super Sanita; 1985; 21(3):327-36. PubMed ID: 3914850
[No Abstract] [Full Text] [Related]
[Next] [New Search]